A systematic review will be conducted using electronic databases: MEDLINE, EMBASE and CINAHL. Additional articles and grey literature will be searched in Google Scholar and reference list of the selected articles. It will include primary studies, national/regional reports and policy documents. Review questions will be framed into different components according to the ECLIPSe framework. Children less than 19 years of age diagnosed with any malignant disorder in LLMICs will be the client group. Studies that have focused on the availability of EML for adult malignancies and care providers\' knowledge of EML for childhood malignancies will not be considered. Only the studies reported in the English language will be included. Mixed methods Appraisal Tool will be used to assess the quality of included studies. Data will be presented as a narrative synthesis.
This research is exempt from ethics approval because the work is carried out on published documents. Findings of this review will be disseminated through a peer-reviewed journal for the authorities in LLMICs to understand the magnitude of the problem and to identify enablers and barriers to take evidence based decisions to improve their health system.
CRD42022334156.
方法:将使用电子数据库进行系统审查:MEDLINE,EMBASE和CINAHL。其他文章和灰色文献将在Google学者和所选文章的参考列表中搜索。它将包括初级研究,国家/区域报告和政策文件。审核问题将根据ECLIPSe框架分为不同的组成部分。在LLMICs中被诊断患有任何恶性疾病的19岁以下的儿童将是客户群体。关注成人恶性肿瘤的EML可用性和护理提供者对儿童恶性肿瘤的EML知识的研究将不被考虑。仅包括以英语报告的研究。混合方法评估工具将用于评估纳入研究的质量。数据将作为叙述性综合呈现。
背景:这项研究免于伦理批准,因为该工作是在已发布的文件上进行的。这项审查的结果将通过同行评审的期刊传播,供低收入国家的当局了解问题的严重性,并确定采取循证决策以改善其卫生系统的推动者和障碍。
■CRD42022334156。